Table 2. Bone mineral density results and laboratory finding in women with SSc and control group.a .
Parameter | SSc (n = 54) | Controls (n = 54) |
Vertebral fractures, n (%) | 13 (24)* | 1 (1,8) |
Lumbar spine | ||
Bone mineral density (g/cm2) | 0.78±0.08* | 0.88±0.07 |
T-score (S.D.) | −2.20±0.30* | −1.20±0.30 |
Femoral neck (S.D.) | ||
Bone mineral density (g/cm2) | 0.56±0.04* | 0.72±0.07 |
T-score (S.D.) | −2.60±0.20* | −1.30±0.30 |
Total Femur (S.D.) | ||
Bone mineral density (g/cm2) | 0.57±0.04* | 0.71±0.06 |
T-score (S.D.) | −2.50±0.30* | −1.40±0.30 |
Stiffness index (SI) (%) | 80.10±5.10* | 94.80±6.10 |
Osteocalcin (pg/mL) | 15.23±3.76* | 6.32±2.01 |
Deoxypyridinoline (pmol/µmol of urinary creatinine) | 23.13±2.64* | 19.32±3.31 |
Parathyroid hormone level (pg/dL) | 72.26±11.23* | 39.64±11.90 |
25-hydroxivitamin D3 (ng/mL) | 18.29±4.05* | 39.57±7.50 |
Calcium (mg/dL) | 9.54±0.48° | 9.42±0.63 |
Phophate (mg/dL) | 4.05±0.58° | 3.95±0.43 |
Vitamin A (µg/dL) | 59.54±14.48° | 62.42±12.63 |
Creatinine (mg/dL) | 0.94±0.18° | 0.96±0.13 |
aData are expressed as means ± S.D.
°P>0.05.
P<0.001.